Micrus Corporation is a medical device company formed in June 1996 with its corporate headquarters in Mountain View, California. The Company is engaged in the design and development of highly differentiated and proprietary interventional neuroradiology (INR) devices and delivery systems. Micrus believes that these devices represent the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysm. Micrus is working with opinion leaders in the fields of interventional neuroradiology and neurosurgery, including L. Nelson Hopkins, M.D., State University of New York Buffalo, Joseph Horton, M.D., University of Alabama, Andrew Molyneux, M.D., Radcliffe Infirmary, United Kingdom, and Pedro Lylyk, M.D. Institute of Neurological Research in Buenos Aries, Argentina. The Micrus ACT™ MicroCoil System received a 510(k) clearance from the Food and Drug Administration (FDA) in the United States and it is CE marked for sale in the European community.
|
|
Spanish |
 |
 |
|
|
|||||||||||
|
|
